HomeDrug Discovery and Development

Drug Discovery and Development

Funding AI’s Takeover of Drug Discovery

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully raised a sum of $110 million Series E financing. Led by a...

Developing a Potential Solution for a Rare but Deadly Disease

A versatile set of capabilities are embedded deep into the human fabric, and yet none can be deemed as valuable as our capability to...

Addressing the Long-Term Impact of COVID

StemCyte has officially announced a significant breakthrough in its Phase IIa clinical trial of HPC, Cord Blood (HPC, CB) for treating Post-COVID Syndrome (Long...

Solving solubilization: overcoming challenges in the formulation development of oral solid dosage forms

For drug developers working on oral solid dosage drug projects, solubility, and therefore bioavailability, is a significant challenge. At present, poor water solubility impacts...

Advancing Animal-Free Organoid Models for Drug Discovery

There is an increasing drive within the pharmaceutical and personal care communities to reduce, if not eliminate, the use of animals in the testing...

Hot Topics